Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.
An analysis of 235 patients with galactorrhea (5.5 per cent males) showed that 20 per cent of all patients, and 34 per cent of women with associated amenorrhea, had radiologically evident pituitary tumors; these patients had the highest serum prolactin concentrations. The largest single group (32 per cent) consisted of women with idiopathic galactorrhea without amenorrhea; prolactin was normal in 86 per cent of these cases. Five patients had the empty-sella syndrome. Prolactin response was tested in selected patients by thyrotropin-releasing hormone, chlorpromazine,  L-dopa, 24-hour sampling and other means. Tests with thyrotropin-releasing hormone were most useful in identifying patients with pituitary tumors. Surgery and radiotherapy lowered prolactin to a similar degree in patients with tumor, but galactorrhea, and amenorrhea often persisted after treatment. The ergot derivatives, bromergocryptine and lergotrile mesylate, lowered prolactin in all 18 patients with idiopathic hyperprolactinemia or pituitary tumor, stopped galactorrhea in over 50 per cent, restored menses in over 70 per cent, and allowed pregnancy in three.
D000172:Acromegaly / Q000503:physiopathology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000568:Amenorrhea / Q000209:etiology; D002640:Chiari-Frommel Syndrome / Q000503:physiopathology; D002648:Child; D003276:Contraceptives, Oral / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005687:Galactorrhea / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D007775:Lactation Disorders / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010901:Pituitary Function Tests; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D011247:Pregnancy; D011388:Prolactin / Q000097:blood / Q000378:metabolism
D003276:Contraceptives, Oral; D011388:Prolactin